[96a5a0]: / output / allTrials / identified / NCT02446431_identified.json

Download this file

690 lines (690 with data), 29.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
{
"info": {
"nct_id": "NCT02446431",
"official_title": "Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence: A Multi-Institutional Study",
"inclusion_criteria": "1. The following solid tumors will be studied: rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, other soft tissue sarcomas\n2. Other solid tumors fulfilling the remainder of eligibility criteria and available historical data to determine time to tumor progression\n3. Expected time to progression of < 2 years, based on historical data\n4. All patients will have completed front-line therapy\n5. All patients will be in remission from their primary diagnosis\n6. All patients will start metronomic therapy within 6 weeks of completion of front-line treatment\n7. All patient will have recovered from previous toxicities\n8. All patients or their parents/legal guardian will have signed an informed consent document\n9. All institutional eligibility criteria will be meet\n10. Age: Patients must be ≥ 12 months and <31 years of age at the time of study entry\n11. Patients must have had histologic verification of malignancy at original diagnosis\n12. Patients must have a Lansky or Karnofsky performance status score of ≥ 50, corresponding to ECOG categories 0, 1 or 2.\n13. Adequate renal function defined as: Normal serum creatinine\n14. Normal liver tests (ALT/AST/total bilirubin/triglycerides/cholesterol)\n15. Recovered from all surgical procedures for at least 7 days (minor procedures) or 28 days (major procedures)\n16. Adequate cardiac function defined as: Shortening fraction of ≥ 27% by echocardiogram, or ejection fraction of ≥ 50% by radionuclide angiogram\n17. Platelet count 100,000K/uL (transfusion independent), hemoglobin 8.0 g/dL\n18. Adequate bone marrow function: Peripheral absolute neutrophil count (ANC) 1,000K/uL\n19. Signed Informed Consent document and/or Assent document\nHealthy volunteers allowed\nMust have minimum age of 12 Months\nMust have maximum age of 31 Years",
"exclusion_criteria": "1. Female patients who are pregnant\n2. Lactating females are not eligible unless they have agreed to discontinue breastfeeding\n3. Female patients of childbearing potential are not eligible unless a negative pregnancy test result has been obtained\n4. Sexually active patients of reproductive potential are not eligible unless they have agreed to use an effective contraceptive method for the duration of study participation\n5. Any primary central nervous system tumor\n6. Any patient who has experienced relapsed or refractory disease or a second malignancy.\n7. Any patient not in remission",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. The following solid tumors will be studied: rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, other soft tissue sarcomas",
"criterions": [
{
"exact_snippets": "solid tumors ... rhabdomyosarcoma",
"criterion": "solid tumor type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "rhabdomyosarcoma"
}
]
},
{
"exact_snippets": "solid tumors ... osteosarcoma",
"criterion": "solid tumor type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "osteosarcoma"
}
]
},
{
"exact_snippets": "solid tumors ... Ewing sarcoma",
"criterion": "solid tumor type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "Ewing sarcoma"
}
]
},
{
"exact_snippets": "solid tumors ... other soft tissue sarcomas",
"criterion": "solid tumor type",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "other soft tissue sarcomas"
}
]
}
]
},
{
"line": "2. Other solid tumors fulfilling the remainder of eligibility criteria and available historical data to determine time to tumor progression",
"criterions": [
{
"exact_snippets": "Other solid tumors",
"criterion": "solid tumors",
"requirements": [
{
"requirement_type": "type",
"expected_value": "solid"
}
]
},
{
"exact_snippets": "available historical data",
"criterion": "historical data",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
},
{
"exact_snippets": "determine time to tumor progression",
"criterion": "time to tumor progression",
"requirements": [
{
"requirement_type": "determinability",
"expected_value": true
}
]
}
]
},
{
"line": "3. Expected time to progression of < 2 years, based on historical data",
"criterions": [
{
"exact_snippets": "Expected time to progression of < 2 years",
"criterion": "time to progression",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 2,
"unit": "years"
}
}
]
}
]
},
{
"line": "4. All patients will have completed front-line therapy",
"criterions": [
{
"exact_snippets": "completed front-line therapy",
"criterion": "front-line therapy",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
}
]
},
{
"line": "5. All patients will be in remission from their primary diagnosis",
"criterions": [
{
"exact_snippets": "patients will be in remission from their primary diagnosis",
"criterion": "remission",
"requirements": [
{
"requirement_type": "status",
"expected_value": "remission"
}
]
}
]
},
{
"line": "6. All patients will start metronomic therapy within 6 weeks of completion of front-line treatment",
"criterions": [
{
"exact_snippets": "start metronomic therapy within 6 weeks of completion of front-line treatment",
"criterion": "metronomic therapy start time",
"requirements": [
{
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "7. All patient will have recovered from previous toxicities",
"criterions": [
{
"exact_snippets": "recovered from previous toxicities",
"criterion": "previous toxicities",
"requirements": [
{
"requirement_type": "recovery",
"expected_value": true
}
]
}
]
},
{
"line": "8. All patients or their parents/legal guardian will have signed an informed consent document",
"criterions": [
{
"exact_snippets": "All patients or their parents/legal guardian will have signed an informed consent document",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "9. All institutional eligibility criteria will be meet",
"criterions": [
{
"exact_snippets": "All institutional eligibility criteria",
"criterion": "institutional eligibility criteria",
"requirements": [
{
"requirement_type": "compliance",
"expected_value": true
}
]
}
]
},
{
"line": "10. Age: Patients must be ≥ 12 months and <31 years of age at the time of study entry",
"criterions": [
{
"exact_snippets": "Age: Patients must be ≥ 12 months and <31 years of age",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 12,
"unit": "months"
},
{
"operator": "<",
"value": 31,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "11. Patients must have had histologic verification of malignancy at original diagnosis",
"criterions": [
{
"exact_snippets": "histologic verification of malignancy",
"criterion": "malignancy verification",
"requirements": [
{
"requirement_type": "method",
"expected_value": "histologic"
}
]
},
{
"exact_snippets": "original diagnosis",
"criterion": "diagnosis timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "original"
}
]
}
]
},
{
"line": "12. Patients must have a Lansky or Karnofsky performance status score of ≥ 50, corresponding to ECOG categories 0, 1 or 2.",
"criterions": [
{
"exact_snippets": "Lansky or Karnofsky performance status score of ≥ 50",
"criterion": "Lansky or Karnofsky performance status score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "corresponding to ECOG categories 0, 1 or 2",
"criterion": "ECOG categories",
"requirements": [
{
"requirement_type": "category",
"expected_value": [
"0",
"1",
"2"
]
}
]
}
]
},
{
"line": "13. Adequate renal function defined as: Normal serum creatinine",
"criterions": [
{
"exact_snippets": "Adequate renal function defined as: Normal serum creatinine",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "serum creatinine level",
"expected_value": "normal"
}
]
}
]
},
{
"line": "14. Normal liver tests (ALT/AST/total bilirubin/triglycerides/cholesterol)",
"criterions": [
{
"exact_snippets": "Normal liver tests (ALT/AST/total bilirubin/triglycerides/cholesterol)",
"criterion": "liver tests",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
}
]
},
{
"line": "15. Recovered from all surgical procedures for at least 7 days (minor procedures) or 28 days (major procedures)",
"criterions": [
{
"exact_snippets": "Recovered from all surgical procedures for at least 7 days (minor procedures)",
"criterion": "recovery from minor surgical procedures",
"requirements": [
{
"requirement_type": "time since procedure",
"expected_value": {
"operator": ">=",
"value": 7,
"unit": "days"
}
}
]
},
{
"exact_snippets": "Recovered from all surgical procedures for at least ... 28 days (major procedures)",
"criterion": "recovery from major surgical procedures",
"requirements": [
{
"requirement_type": "time since procedure",
"expected_value": {
"operator": ">=",
"value": 28,
"unit": "days"
}
}
]
}
]
},
{
"line": "16. Adequate cardiac function defined as: Shortening fraction of ≥ 27% by echocardiogram, or ejection fraction of ≥ 50% by radionuclide angiogram",
"criterions": [
{
"exact_snippets": "Adequate cardiac function defined as: Shortening fraction of ≥ 27% by echocardiogram",
"criterion": "cardiac function",
"requirements": [
{
"requirement_type": "shortening fraction",
"expected_value": {
"operator": ">=",
"value": 27,
"unit": "%"
}
}
]
},
{
"exact_snippets": "Adequate cardiac function defined as: ... ejection fraction of ≥ 50% by radionuclide angiogram",
"criterion": "cardiac function",
"requirements": [
{
"requirement_type": "ejection fraction",
"expected_value": {
"operator": ">=",
"value": 50,
"unit": "%"
}
}
]
}
]
},
{
"line": "17. Platelet count 100,000K/uL (transfusion independent), hemoglobin 8.0 g/dL",
"criterions": [
{
"exact_snippets": "Platelet count 100,000K/uL",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "K/uL"
}
}
]
},
{
"exact_snippets": "transfusion independent",
"criterion": "transfusion independence",
"requirements": [
{
"requirement_type": "status",
"expected_value": true
}
]
},
{
"exact_snippets": "hemoglobin 8.0 g/dL",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 8.0,
"unit": "g/dL"
}
}
]
}
]
},
{
"line": "18. Adequate bone marrow function: Peripheral absolute neutrophil count (ANC) 1,000K/uL",
"criterions": [
{
"exact_snippets": "Adequate bone marrow function: Peripheral absolute neutrophil count (ANC) 1,000K/uL",
"criterion": "peripheral absolute neutrophil count (ANC)",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": {
"operator": ">=",
"value": 1000,
"unit": "K/uL"
}
}
]
}
]
},
{
"line": "19. Signed Informed Consent document and/or Assent document",
"criterions": [
{
"exact_snippets": "Signed Informed Consent document",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
},
{
"exact_snippets": "Assent document",
"criterion": "assent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 12 Months",
"criterions": [
{
"exact_snippets": "minimum age of 12 Months",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "Months"
}
}
]
}
]
},
{
"line": "Must have maximum age of 31 Years",
"criterions": [
{
"exact_snippets": "maximum age of 31 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 31,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Female patients who are pregnant",
"criterions": [
{
"exact_snippets": "Female patients",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "who are pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "value",
"expected_value": true
}
]
}
]
},
{
"line": "2. Lactating females are not eligible unless they have agreed to discontinue breastfeeding",
"criterions": [
{
"exact_snippets": "Lactating females are not eligible",
"criterion": "lactating females",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
},
{
"exact_snippets": "unless they have agreed to discontinue breastfeeding",
"criterion": "discontinuation of breastfeeding",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
}
]
},
{
"line": "3. Female patients of childbearing potential are not eligible unless a negative pregnancy test result has been obtained",
"criterions": [
{
"exact_snippets": "Female patients of childbearing potential",
"criterion": "female patients of childbearing potential",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
},
{
"exact_snippets": "negative pregnancy test result has been obtained",
"criterion": "pregnancy test result",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "4. Sexually active patients of reproductive potential are not eligible unless they have agreed to use an effective contraceptive method for the duration of study participation",
"criterions": [
{
"exact_snippets": "Sexually active patients of reproductive potential",
"criterion": "sexual activity and reproductive potential",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": false
}
]
},
{
"exact_snippets": "agreed to use an effective contraceptive method",
"criterion": "contraceptive use",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
}
]
},
{
"line": "5. Any primary central nervous system tumor",
"criterions": [
{
"exact_snippets": "primary central nervous system tumor",
"criterion": "primary central nervous system tumor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "6. Any patient who has experienced relapsed or refractory disease or a second malignancy.",
"criterions": [
{
"exact_snippets": "relapsed or refractory disease",
"criterion": "disease status",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"relapsed",
"refractory"
]
}
]
},
{
"exact_snippets": "second malignancy",
"criterion": "malignancy",
"requirements": [
{
"requirement_type": "occurrence",
"expected_value": "second"
}
]
}
]
},
{
"line": "7. Any patient not in remission",
"criterions": [
{
"exact_snippets": "patient not in remission",
"criterion": "remission status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "not in remission"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}